BrainGate2 clinical trial (speech neuroprosthesis)
Photo: PaulWicks at English Wikipedia · Public domain (opens commons.wikimedia.org)

BrainGate2 clinical trial (speech neuroprosthesis)

by BrainGate consortiumUS

Restore natural, conversational speech to people with severe paralysis, dysarthria, or ALS-induced speech loss.

DeployStage 4 of 5

Ongoing multi-site trial; 97% accuracy (2024); inner speech decoding in Cell 2025.

Updated Feb 2026Checked 11 Oct0 updates this week

Milestones

Next · UC Davis speech trial recruiting
  1. First BrainGate trial initiated (original)2004Complete.
  2. FDA approves BrainGate2 IDEJul 2009Complete.
  3. Stanford joins BrainGate2 consortiumNov 2011Complete.
  4. First 3D robotic arm control by tetraplegia patients2012Complete.
  5. ALS patient achieves 97% speech decoding accuracyAug 2024Complete.
  6. Inner speech decoding published in Cell2025Complete.
  7. UC Davis speech trial recruitingTarget Aug 2022Current milestone.
Primer